CEO Marty Lyons highlighted Ameren's ongoing commitment to its strategic plan focusing on delivering reliable and affordable energy. Key investments in energy infrastructure have enhanced system ...

Novo Nordisk's shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity ...

Ameren expects a 5.5% compound annual sales growth in Missouri from 2025 to 2029, primarily driven by increasing data center demand. The company signed construction agreements for data centers ...